SE Intimation- Meeting with Analyst Institutional Investor
Intimation - Appointment of Managing Director - Pfizer Limited
Stock Exchange Intimation - Interim Injunction on the prohibition of the manufacture and sale of the Corex -Pfizer Limited- March 14, 2016
Stock Exchange intimation-Prohibition on sale of drug Chlopheniramine Maleate + Codeine Syrup - March 14, 2016
Institutional Investors Meet Pfizer Limited
Intimation to Stock Exchanges – Analysts call - Results for the quarter ended December 31, 2015
Notice of Board Meeting – February 3, 2016
Appointment of Director – Ms. Lu Hong
Contact Details of the Authorized Key Managerial Personnel under Regulation 30(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation to Stock Exchanges regarding Pfizer Inc. and Allergan Plc to combine
Pfizer Limited – Change of Registered Address
Notice of the Board Meeting – November 9, 2015
Resignation of Managing Director – Mr. Aijaz Tobaccowalla.
Pfizer completes Acquisition of Hospira
Resignation of Executive Director – Dr. Lakshmi Nadkarni
Withdrawal of Thane Plant Closure Notice.
Business Transfer Agreement with Vidhi Research and Development LLP for sale of Thane Plant.
Pfizer Limited – 64th AGM evoting and poll results
Notice of the Board Meeting – July 25, 2015
Notice of the Board Meeting – May 5, 2015
Intimation pursuant to Clause 30 of the Listing Agreement – February 14, 2015.
Notice of the Board Meeting – February 14, 2015
Pfizer Limited evoting results – 63th Annual General Meeting

Results :
Pfizer Global    SITEMAP | CONTACT US   
Copyright © 2009 Pfizer Limited, India. All rights reserved. Bookmark this page | Feedback | Terms of Use
The product information provided in this site is intended only for residents of India. The products discussed herein may have different product labeling in different countries.
Site best viewed in Internet Explorer 5.5 + & Netscape Navigator 7.0 + with screen resolution of 1024 x 768 pixels.